FundedIQ
Biotechnology

VALANX Biotech: Funding, Investors & Team (Sep 2026)

VALANX Biotech creates a unique method of attaching proteins to specific sites for use in treatments, diagnoses, and biocatalysis.

valanx.bio LinkedIn Graz, Austria 1-10 employees
Biotechnology Health Care Medical Pharmaceutical B2B
Total raised
$6.0M
Rounds
2
Latest
Undisclosed round
Mar 2026

VALANX Biotech has raised $6.0M across 2 funding rounds on record, the most recent an undisclosed round of $3.5M announced in Mar 2026.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

VALANX Biotech Company Profile and Key Stats

Total funding raised
$6.0M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Undisclosed round
$3.5M in Mar 2026
Employees
1-10
reported band
Headquarters
Graz, Austria

Latest funding round on record: Mar 2026.

VALANX Biotech Funding Rounds

Date
Round
Amount
Undisclosed round
$3.5M
Seed
$2.5M

VALANX Biotech raised $2.5M in a Seed announced in Nov 2023.

2.3 years later, an undisclosed round of $3.5M was announced in Mar 2026.

VALANX Biotech Founders and Leadership Team

Name
Role
Contact
Michael Lukesch Osterreich | Berufliches Profil
Founder
Locked
Michael Lukesch
CEO

Contact details for the VALANX Biotech team: 1 has a LinkedIn profile.

Start 14-day free trial →

VALANX Biotech Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
195
$4.0M

VALANX Biotech's latest round of $3.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like VALANX Biotech in Biotechnology and Graz

Companies Similar to VALANX Biotech

Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell…

Seed $5.0M

aTension.life is a company dedicated to improving the diagnosis and treatment of hypertension using precision…

Seed $3.0M

Millions of people worldwide suffer from brain-related issues that can already be addressed with the latest…

Undisclosed round $800k

Hookipa Biotech is a clinical stage company developing next-generation immunotherapies for infectious…

Undisclosed round $21.3M

The patented technology developed by Lignovations allows for the creation of lignin particles in the…

Seed $2.4M

Sarcura creates a machine platform for the mass production of customized cell therapies in industry. Our goal…

Seed $7.3M

Arkeon Bio is a biotechnology company that captures CO2 from industry and converts inorganic gases into…

Seed $7.1M

Celeris Therapeutics is a deep learning company that uses innovative, computer-based methods to degrade…

Seed $3.4M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…

Seed $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…

Series A $40.0M

VALANX Biotech Funding FAQs

What does VALANX Biotech do?

VALANX Biotech creates a unique method of attaching proteins to specific sites for use in treatments, diagnoses, and biocatalysis.

How much funding has VALANX Biotech raised?

VALANX Biotech has raised $6.0M across 2 rounds on record. The most recent is an undisclosed round of $3.5M announced in Mar 2026.

When did VALANX Biotech last raise funding?

VALANX Biotech's most recent funding round on record is an undisclosed round of $3.5M, announced in Mar 2026.

Who founded VALANX Biotech?

FundedIQ lists Michael Lukesch Osterreich | Berufliches Profil (Founder) at VALANX Biotech.

Who is the CEO of VALANX Biotech?

Michael Lukesch is listed as CEO at VALANX Biotech.

Where is VALANX Biotech headquartered?

VALANX Biotech is based in Graz, Steiermark, Austria.

How many employees does VALANX Biotech have?

VALANX Biotech is in the 1-10 employee band.

How does VALANX Biotech's funding compare to other Biotechnology startups?

VALANX Biotech's latest round of $3.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's VALANX Biotech Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for VALANX Biotech is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.